Inventor
EL-DEIRY WAFIK S
US24 patents
⚠️ This page may combine multiple inventors who share the name “EL-DEIRY WAFIK S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INSTITUTE FOR CANCER RES
14 patentsUS10987356B2Apr 27, 2021
Dual inhibition of CDK and HSP90 destabilize H1F1 α and synergistically induces cancer cell death
INSTITUTE FOR CANCER RES2 citations73
US11578324B2Feb 14, 2023
miR-3132 upregulation of the TRAIL pathway and apoptotic activity in cancer cells
INSTITUTE FOR CANCER RES2 citations69
US10729692B2Aug 4, 2020
Dual inhibition of CDK and HSP90 destabilize HIF1alpha and synergistically induces cancer cell death
INSTITUTE FOR CANCER RES1 citations62
US12595483B2Apr 7, 2026
Treatment of tumors with miRNA targeting CDK4/CDK6
INSTITUTE FOR CANCER RES0 citations59
US12344599B2Jul 1, 2025
Prodigiosin analogs and methods of use
INSTITUTE FOR CANCER RES0 citations59
US12071622B2Aug 27, 2024
miR-3132 upregulation of the trail pathway and apoptotic activity in cancer cells
INSTITUTE FOR CANCER RES0 citations59
US11993589B2May 28, 2024
Prodigiosin analogs and methods of use
INSTITUTE FOR CANCER RES0 citations59
US11859183B2Jan 2, 2024
Treatment of tumors with miRNA targeting CDK4/CDK6
INSTITUTE FOR CANCER RES0 citations59
US11535608B2Dec 27, 2022
Prodigiosin analogs and methods of use
INSTITUTE FOR CANCER RES0 citations59
US11034959B2Jun 15, 2021
Treatment of tumors with miRNA targeting CDK4/CDK6
INSTITUTE FOR CANCER RES0 citations59
US11203598B2Dec 21, 2021
Compounds for repressing cancer cell growth
INSTITUTE FOR CANCER RES1 citations54
US12098428B2Sep 24, 2024
Frequent EGFR and NTRK somatic mutations in colorectal cancer (CRC) with microsatellite instability (MSI)
INSTITUTE FOR CANCER RES0 citations50
US10870640B2Dec 22, 2020
Prodigiosin analogs and methods of use
INSTITUTE FOR CANCER RES0 citations48
US10654801B2May 19, 2020
Prodigiosin analogs
INSTITUTE FOR CANCER RES0 citations48
PENN STATE RES FOUND
8 patentsUSRE46290EJan 31, 2017
Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
PENN STATE RES FOUND6 citations83
US10322123B2Jun 18, 2019
Compound for anti-cancer therapy that acts by targeting GOF mutant P53 and stimulates P73 to restore the P53 pathway signaling
PENN STATE RES FOUND2 citations70
US12036223B2Jul 16, 2024
Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
PENN STATE RES FOUND0 citations61
US9629842B2Apr 25, 2017
Small molecule TRAIL gene induction by normal and tumor cells as an anticancer therapy
PENN STATE RES FOUND1 citations61
US9452165B2Sep 27, 2016
Small molecule TRAIL gene induction by normal and tumor cells as an anticancer therapy
PENN STATE RES FOUND1 citations61
US9072744B1Jul 7, 2015
Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
PENN STATE RES FOUND1 citations61
US9061032B2Jun 23, 2015
Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
PENN STATE RES FOUND1 citations61
US10744133B2Aug 18, 2020
Compound for anti-cancer therapy that acts by targeting GOF mutant p53 and stimulates p73 to restore the p53 pathway signaling
PENN STATE RES FOUND0 citations49